• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR介导的DKK3表达激活减弱前列腺癌中的TGF-β信号传导。

CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-β Signaling in Prostate Cancer.

作者信息

Kardooni Hoda, Gonzalez-Gualda Estela, Stylianakis Emmanouil, Saffaran Sina, Waxman Jonathan, Kypta Robert M

机构信息

Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.

School of Engineering, University of Warwick, Coventry CV4 7AL, UK.

出版信息

Cancers (Basel). 2018 May 28;10(6):165. doi: 10.3390/cancers10060165.

DOI:10.3390/cancers10060165
PMID:29843383
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6025141/
Abstract

The gene encodes a secreted protein, Dkk-3, that inhibits prostate tumor growth and metastasis. is downregulated by promoter methylation in many types of cancer, including prostate cancer. Gene silencing studies have shown that Dkk-3 maintains normal prostate epithelial cell homeostasis by limiting TGF-β/Smad signaling. While ectopic expression of Dkk-3 leads to prostate cancer cell apoptosis, it is unclear if Dkk-3 has a physiological role in cancer cells. Here, we show that treatment of PC3 prostate cancer cells with the DNA methyltransferase (DNMT) inhibitor decitabine demethylates the promoter, induces DKK3 expression, and inhibits TGF-β/Smad-dependent transcriptional activity. Direct induction of DKK3 expression using CRISPR-dCas9-VPR also inhibited TGF-β/Smad-dependent transcription and attenuated PC3 cell migration and proliferation. These effects were not observed in C4-2B cells, which do not respond to TGF-β. TGF-β signals can regulate gene expression directly via SMAD proteins and indirectly by increasing DNMT expression, leading to promoter methylation. Analysis of genes downregulated by promoter methylation and predicted to be regulated by TGF-β found that DKK3 induction increased expression of PTGS2, which encodes cyclooxygenase-2. Together, these observations provide support for using CRISPR-mediated induction of DKK3 as a potential therapeutic approach for prostate cancer and highlight complexities in Dkk-3 regulation of TGF-β signaling.

摘要

该基因编码一种分泌蛋白Dkk-3,它可抑制前列腺肿瘤的生长和转移。在包括前列腺癌在内的多种癌症中,其因启动子甲基化而下调。基因沉默研究表明,Dkk-3通过限制TGF-β/Smad信号传导来维持前列腺上皮细胞的正常稳态。虽然Dkk-3的异位表达会导致前列腺癌细胞凋亡,但尚不清楚Dkk-3在癌细胞中是否具有生理作用。在此,我们表明用DNA甲基转移酶(DNMT)抑制剂地西他滨处理PC3前列腺癌细胞可使启动子去甲基化,诱导DKK3表达,并抑制TGF-β/Smad依赖的转录活性。使用CRISPR-dCas9-VPR直接诱导DKK3表达也抑制了TGF-β/Smad依赖的转录,并减弱了PC3细胞的迁移和增殖。在对TGF-β无反应的C4-2B细胞中未观察到这些效应。TGF-β信号可通过SMAD蛋白直接调节基因表达,并通过增加DNMT表达间接调节,从而导致启动子甲基化。对因启动子甲基化而下调且预计受TGF-β调节的基因进行分析发现,DKK3的诱导增加了编码环氧化酶-2的PTGS2的表达。总之,这些观察结果为使用CRISPR介导的DKK3诱导作为前列腺癌的潜在治疗方法提供了支持,并突出了Dkk-3对TGF-β信号传导调节的复杂性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/2e660803f8ab/cancers-10-00165-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/03887d03ef20/cancers-10-00165-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/91e7a96ac87c/cancers-10-00165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/2a9c62bdaf30/cancers-10-00165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/e7841937272e/cancers-10-00165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/fdf683b250b7/cancers-10-00165-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/e32f64545aad/cancers-10-00165-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/2e660803f8ab/cancers-10-00165-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/03887d03ef20/cancers-10-00165-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/91e7a96ac87c/cancers-10-00165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/2a9c62bdaf30/cancers-10-00165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/e7841937272e/cancers-10-00165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/fdf683b250b7/cancers-10-00165-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/e32f64545aad/cancers-10-00165-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b212/6025141/2e660803f8ab/cancers-10-00165-g007.jpg

相似文献

1
CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-β Signaling in Prostate Cancer.CRISPR介导的DKK3表达激活减弱前列腺癌中的TGF-β信号传导。
Cancers (Basel). 2018 May 28;10(6):165. doi: 10.3390/cancers10060165.
2
Dickkopf-3 regulates prostate epithelial cell acinar morphogenesis and prostate cancer cell invasion by limiting TGF-β-dependent activation of matrix metalloproteases.Dickkopf-3通过限制基质金属蛋白酶的TGF-β依赖性激活来调节前列腺上皮细胞腺泡形态发生和前列腺癌细胞侵袭。
Carcinogenesis. 2016 Jan;37(1):18-29. doi: 10.1093/carcin/bgv153. Epub 2015 Oct 26.
3
Downregulation of Dickkopf-3 disrupts prostate acinar morphogenesis through TGF-β/Smad signalling.Dickkopf-3 的下调通过 TGF-β/Smad 信号通路破坏前列腺腺泡形态发生。
J Cell Sci. 2013 Apr 15;126(Pt 8):1858-67. doi: 10.1242/jcs.119388. Epub 2013 Feb 26.
4
Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1.基质 Dickkopf-3 在前列腺癌中的保护作用:TGFBI 和 ECM-1 的作用相反。
Oncogene. 2018 Sep;37(39):5305-5324. doi: 10.1038/s41388-018-0294-0. Epub 2018 Jun 1.
5
Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A.双氢睾酮抑制芳基硫酸酯酶B和Dickkopf Wnt信号通路抑制剂(DKK)-3,导致前列腺上皮中Wnt信号增强,以响应基质Wnt3A。
Prostate. 2019 May;79(7):689-700. doi: 10.1002/pros.23776. Epub 2019 Feb 22.
6
DKK3 regulates cell proliferation, apoptosis and collagen synthesis in keloid fibroblasts via TGF-β1/Smad signaling pathway.DKK3通过TGF-β1/Smad信号通路调节瘢痕疙瘩成纤维细胞的细胞增殖、凋亡和胶原合成。
Biomed Pharmacother. 2017 Jul;91:174-180. doi: 10.1016/j.biopha.2017.03.044. Epub 2017 Apr 28.
7
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.Wnt信号通路在人类乳腺癌中的作用:假定的Wnt抑制剂Dickkopf-3(DKK3)在乳腺肿瘤中常常因启动子高甲基化而表达受抑。
Breast Cancer Res. 2008;10(5):R82. doi: 10.1186/bcr2151. Epub 2008 Sep 30.
8
Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3).硫酸软骨素酶通过对SHP2、磷酸化ERK1/2和Dickkopf Wnt信号通路抑制剂(DKK3)的作用,在前列腺干细胞中差异调节Wnt信号。
Oncotarget. 2017 Oct 27;8(59):100242-100260. doi: 10.18632/oncotarget.22152. eCollection 2017 Nov 21.
9
Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers?Dickkopf 同源物 3(DKK3):癌症检测和治疗的候选物?
J Cell Physiol. 2018 Jun;233(6):4595-4605. doi: 10.1002/jcp.26313. Epub 2018 Jan 15.
10
Dickkopf-3 function in the prostate: implications for epithelial homeostasis and tumor progression.Dickkopf-3在前列腺中的作用:对上皮细胞稳态和肿瘤进展的影响
Bioarchitecture. 2013 Mar-Apr;3(2):42-4. doi: 10.4161/bioa.25243. Epub 2013 Mar 1.

引用本文的文献

1
Precision scalpels for the epigenome: next-gen editing tools in targeted therapies.用于表观基因组的精密手术刀:靶向治疗中的新一代编辑工具。
Front Med (Lausanne). 2025 Jun 17;12:1613722. doi: 10.3389/fmed.2025.1613722. eCollection 2025.
2
UHRF1 phase separation mediates stable inheritance of DNA methylation and promotes the proliferation of prostate cancer cells.UHRF1相分离介导DNA甲基化的稳定遗传并促进前列腺癌细胞的增殖。
Cell Commun Signal. 2025 Jun 20;23(1):297. doi: 10.1186/s12964-025-02309-6.
3
Role of DNA methylation transferase in urinary system diseases: From basic to clinical perspectives (Review).

本文引用的文献

1
Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1.基质 Dickkopf-3 在前列腺癌中的保护作用:TGFBI 和 ECM-1 的作用相反。
Oncogene. 2018 Sep;37(39):5305-5324. doi: 10.1038/s41388-018-0294-0. Epub 2018 Jun 1.
2
Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer.卷曲蛋白 8 在前列腺癌中整合 Wnt-11 和转化生长因子-β信号通路。
Nat Commun. 2018 May 1;9(1):1747. doi: 10.1038/s41467-018-04042-w.
3
Targeting DNA Methyltranferases in Urological Tumors.
DNA 甲基转移酶在泌尿系统疾病中的作用:从基础到临床的角度(综述)。
Int J Mol Med. 2025 Feb;55(2). doi: 10.3892/ijmm.2024.5460. Epub 2024 Nov 22.
4
Targeting mRNA-coding genes in prostate cancer using CRISPR/Cas9 technology with a special focus on androgen receptor signaling.使用 CRISPR/Cas9 技术靶向前列腺癌中的 mRNA 编码基因,特别关注雄激素受体信号。
Cell Commun Signal. 2024 Oct 17;22(1):504. doi: 10.1186/s12964-024-01833-1.
5
Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival.基于免疫脂质体的CRISPR/Cas9 gRNA-IL30复合物靶向递送可抑制前列腺癌并延长生存期。
Exp Mol Med. 2024 Sep;56(9):2033-2051. doi: 10.1038/s12276-024-01310-2. Epub 2024 Sep 4.
6
Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine.3P医学框架下的多方面CRISPR/Cas技术创新层面
EPMA J. 2023 May 22;14(2):201-217. doi: 10.1007/s13167-023-00324-6. eCollection 2023 Jun.
7
Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma.CRISPRa 技术介导的肿瘤抑制基因表观遗传激活作为肝细胞癌精准治疗的策略。
Clin Epigenetics. 2023 Apr 29;15(1):73. doi: 10.1186/s13148-023-01482-0.
8
Dickkopf-3: An Update on a Potential Regulator of the Tumor Microenvironment.Dickkopf-3:肿瘤微环境潜在调节因子的最新进展
Cancers (Basel). 2022 Nov 25;14(23):5822. doi: 10.3390/cancers14235822.
9
Advances in CRISPR therapeutics.CRISPR 疗法的进展。
Nat Rev Nephrol. 2023 Jan;19(1):9-22. doi: 10.1038/s41581-022-00636-2. Epub 2022 Oct 24.
10
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality.CRISPR/Cas9 介导的白细胞介素-30 缺失抑制 IGF1 和 CXCL5 并增强 SOCS3 减少前列腺癌生长和死亡率。
J Hematol Oncol. 2022 Oct 13;15(1):145. doi: 10.1186/s13045-022-01357-6.
靶向泌尿肿瘤中的DNA甲基转移酶
Front Pharmacol. 2018 Apr 13;9:366. doi: 10.3389/fphar.2018.00366. eCollection 2018.
4
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
5
In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.通过CRISPR/Cas9介导的反式表观遗传调控实现体内靶基因激活
Cell. 2017 Dec 14;171(7):1495-1507.e15. doi: 10.1016/j.cell.2017.10.025. Epub 2017 Dec 7.
6
The role of TET-mediated DNA hydroxymethylation in prostate cancer.TET 介导的 DNA 羟甲基化在前列腺癌中的作用。
Mol Cell Endocrinol. 2018 Feb 15;462(Pt A):41-55. doi: 10.1016/j.mce.2017.08.021. Epub 2017 Sep 1.
7
Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.雄激素剥夺治疗后 SPDEF 的缺失和 TGFBI 活性的获得促进前列腺癌的 EMT 和骨转移。
Sci Signal. 2017 Aug 15;10(492):eaam6826. doi: 10.1126/scisignal.aam6826.
8
The Dkk3 gene encodes a vital intracellular regulator of cell proliferation.Dkk3基因编码一种细胞增殖的重要细胞内调节因子。
PLoS One. 2017 Jul 24;12(7):e0181724. doi: 10.1371/journal.pone.0181724. eCollection 2017.
9
DNMT1 regulates IL-6- and TGF-β1-induced epithelial mesenchymal transition in prostate epithelial cells.DNMT1调节白细胞介素-6和转化生长因子-β1诱导的前列腺上皮细胞上皮-间质转化。
Eur J Histochem. 2017 May 3;61(2):2775. doi: 10.4081/ejh.2017.2775.
10
Exploiting Epigenetic Alterations in Prostate Cancer.利用前列腺癌中的表观遗传改变
Int J Mol Sci. 2017 May 9;18(5):1017. doi: 10.3390/ijms18051017.